First published in The Pharma Letter on July 4, 2024

Getting the most out of AI foundation models: tips for pharmaceutical companies

By Brendan Frey,  Founder and Chief Innovation Officer of Deep Genomics     

We’ve all heard of and used ChatGPT. But what if we ...

3 biotechs lease space at Cambridge office-to-lab conversion

First published by Greg Ryan – Senior Reporter at the Boston Business Journal on May 22, 2024

A Tishman Speyer joint venture has signed small leases with three biotechs at a Cambridge office-to-lab conversion, leaving about two-thirds of ...